April 16, 2021
March 2021: Meducom provides publication support of important Finnish colorectal cancer study
Colorectal cancer (CRC) is the third most common cancer worldwide with 1.8 million new cases…
Read More
April 13, 2021
November 2020: Expert medical support for regulatory affairs and dossiers
Tailored expert medical communication is becoming more and more important. With our expertise, Meducom increasingly…
Read More
July 7, 2020
June 2020: Supporting review on management of chemotherapy-induced HFS
Although Hand-Foot Syndrome (HFS) is not life threatening, it can cause a significant discomfort and impairment of function. Especially…
Read More
July 6, 2020
March 2020: Meducom celebrates its 15th anniversary!
Following 10 years of academic medical research combined with many years of experience in the…
Read More
June 18, 2020
November 2019: Meducom wins competitive pitch
At the end of 2019, Meducom was invited by an international biotechnology company specialised in…
Read More
June 18, 2020
September 2019: Meducom supports regulatory affairs with safety reports
Periodic Safety Update Reports (PSURs) and Periodic Benefit-Risk Evaluation Reports (PBRERs) are typical pharmacovigilance documents.…
Read More
November 15, 2019
July 2019: Meducom supports development guidance and recommendations to address complications of rare disease
Gaucher disease (GD) is a rare, genetic lysosomal disorder leading to lipid accumulation and dysfunction…
Read More
November 12, 2019
March 2019: Meducom supports manuscript development
March 2019: Meducom supports manuscript development on real-life experiences in the treatment of gastric cancer…
Read More
June 21, 2018
June 2018 Meducom launches her totally renewed website
With pride we present our totally renewed website with a fresh and contemporary look. Our…
Read More
May 18, 2018
April 2018: Development “toolbox” use MRI with MS patients
Over the past months, Meducom developed for one of her clients an educational modular program…
Read More